Organisation paid for research Program year 2025 Source: CMS Open Payments

Oculus Research Inc.

Neither a doctor nor a teaching hospital

Research payments

$523,687

16 payments

Through program year 2025, Oculus Research Inc. is reported as receiving $523,687 in research payments, across 16 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$354,475	3
2024	Research	$59,943	7
2023	Research	$84,036	4
2019	Research	$25,233	2

Breakdown

Who paid Research payments · program years 2019–2025

Bausch & Lomb Americas Inc. $498,455 14 payments
Ocular Therapeutix, Inc. $25,233 2 payments

Studies the money was for Research payments · program years 2019–2025

A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness $354,475 3 payments
A Safety and Effectiveness Study of a Contact Lens Cleaning and Disinfecting Solution $111,520 8 payments
A Multicenter, Double-Masked, Randomized, Placebo-Controlled Phase 3 Study of the Safety and Efficacy of Atropine 0.1% and 0.01% Ophthalmic Solutions Administered With a Microdose Dispenser for the Reduction of Pediatric Myopia Progression $32,460 3 payments
A Prospective, Multicenter, Open Label Extension Study to Evaluate the Long Term Safety of OTX-TP $22,583 1 payment
A Prospective, Multicenter, Randomized, Parallel-Arm, Double Masked, Vehicle Controlled Phase 3a Study Evaluating the Safety and Efficacy of OTX-TP in the Treatment of Subjects With Open-Angle Glaucoma or Ocular Hypertension $2,650 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.